Guidance for industry : waiver of in vivo bioavailability studies for immediate-release soild oral dosage forms based on a biopharmaceutics classification system.
Saved in:
| Imprint: | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2000] |
|---|---|
| Description: | 1 electronic resource (13 pages) |
| Language: | English |
| Subject: | |
| Format: | E-Resource U.S. Federal Government Document Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/7993059 |